Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | CES2 | O00748 | 2/20 | 0.37 |
| ▸ | KDM1A | O60341 | 2/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.37 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.37 |
| ▸ | EED | O75530 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SUZ12 | Q15022 | 1/20 | 0.37 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.37 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13995068 | 0.83 | — | — | |
| SCHEMBL5011685 | 0.83 | NPC1 (0.40) | CYP1A2MAPTALDH1A1KDM4EHPGD | |
| SCHEMBL13995133 | 0.83 | COMT (0.39) | MAPTTDP1POLBALDH1A1KDM4E | |
| SCHEMBL13995076 | 0.81 | ALDH1A1 (0.37) | CYP1A2MAPTHIF1AALDH1A1KDM4E | |
| SCHEMBL16805207 | 0.81 | GPR84 (0.36) | MAPTTDP1KDM4EMEN1KMT2A | |
| SCHEMBL4079264 | 0.80 | DHFR (0.43) | MAPTTDP1ALDH1A1KDM4EHPGD | |
| SCHEMBL4084177 | 0.80 | DHFR (0.43) | MAPTTDP1ALDH1A1KDM4EHPGD | |
| SCHEMBL2380918 | 0.80 | CYP1A2 (0.68) | CYP1A2MAPTHIF1AEPAS1TDP1 | |
| SCHEMBL260441 | 0.80 | CYP1A2 (0.68) | CYP1A2MAPTHIF1AEPAS1TDP1 | |
| SCHEMBL29416731 | 0.80 | CYP1A2 (0.68) | CYP1A2MAPTHIF1AEPAS1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8795847-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2014-08-05 | — | — | US | disclosed |
| US-8795847-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2014-08-05 | — | — | US | disclosed |
| US-20080303003-A1 | Novel Materials for Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080303003-A1 | Novel Materials for Organic Electroluminescent Devices | ANXA2, ANXA3, ANXA1 | CYP1A2 2362/4885MAPT 1988/4885HIF1A 4736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.